Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Chemical-drug catalogue
Loaded records: 50 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 49 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 合肥合源药业有限公司 | 合肥合源药业有限公司 | 国药准字H20265802 | 2026/09/02 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 合肥合源药业有限公司 | 合肥合源药业有限公司 | 国药准字H20265803 | 2026/09/02 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 海南倍吉康医药科技有限公司 | 济南高华制药有限公司 | 国药准字H20265824 | 2026/09/02 | 5mg(以C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 海南倍吉康医药科技有限公司 | 济南高华制药有限公司 | 国药准字H20265825 | 2026/09/02 | 10mg(以C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 新石阳光药业(河北)有限公司 | 新石阳光药业(河北)有限公司 | 国药准字H20265732 | 2026/08/25 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 新石阳光药业(河北)有限公司 | 新石阳光药业(河北)有限公司 | 国药准字H20265731 | 2026/08/25 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 山东新华制药股份有限公司 | 济南高华制药有限公司 | 国药准字H20265670 | 2026/08/18 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 山东新华制药股份有限公司 | 济南高华制药有限公司 | 国药准字H20265648 | 2026/08/18 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 浙江宏元药业股份有限公司 | 九洲生物医药(台州)有限公司 | 国药准字H20265370 | 2026/07/28 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 浙江宏元药业股份有限公司 | 九洲生物医药(台州)有限公司 | 国药准字H20265369 | 2026/07/28 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 上海现代制药股份有限公司 | 上海现代制药股份有限公司 | 国药准字H20265326 | 2026/07/21 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 上海现代制药股份有限公司 | 上海现代制药股份有限公司 | 国药准字H20265325 | 2026/07/21 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 浙江京新药业股份有限公司 | 浙江京新药业股份有限公司 | 国药准字H20265058 | 2026/06/30 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 浙江京新药业股份有限公司 | 浙江京新药业股份有限公司 | 国药准字H20265057 | 2026/06/30 | 5mg (按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 山东新时代药业有限公司 | 山东新时代药业有限公司 | 国药准字H20269126 | 2026/05/26 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| ALEMBIC PHARMACEUTICALS LIMITED, FORMULATION DIVISION | ALEMBIC PHARMACEUTICALS LIMITED, FORMULATION DIVISION | 国药准字HJ20260050 | 2026/05/20 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| ALEMBIC PHARMACEUTICALS LIMITED, FORMULATION DIVISION | ALEMBIC PHARMACEUTICALS LIMITED, FORMULATION DIVISION | 国药准字HJ20260051 | 2026/05/20 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 辰欣药业股份有限公司 | 辰欣药业股份有限公司 | 国药准字H20263949 | 2026/04/14 | 10mg(按C21H25ClO6计) | Not stated by source | CDE |
| 辰欣药业股份有限公司 | 辰欣药业股份有限公司 | 国药准字H20263950 | 2026/04/14 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 辽宁鑫善源药业有限公司 | 辽宁鑫善源药业有限公司 | 国药准字H20263619 | 2026/03/17 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 辽宁鑫善源药业有限公司 | 辽宁鑫善源药业有限公司 | 国药准字H20263620 | 2026/03/17 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 石家庄市华新药业有限责任公司 | 石家庄市华新药业有限责任公司 | 国药准字H20263477 | 2026/02/25 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 任曦医药科技河北有限公司 | 天方药业有限公司 | 国药准字H20263290 | 2026/02/02 | 10mg (按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 山西德元堂药业有限公司 | 山西德元堂药业有限公司 | 国药准字H20263204 | 2026/01/27 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 山西德元堂药业有限公司 | 山西德元堂药业有限公司 | 国药准字H20263203 | 2026/01/27 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 郑州泰丰制药有限公司 | 郑州泰丰制药有限公司 | 国药准字H20263217 | 2026/01/27 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 郑州泰丰制药有限公司 | 郑州泰丰制药有限公司 | 国药准字H20263216 | 2026/01/27 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 海南倍康医药科技有限公司 | 成都倍特药业股份有限公司 | 国药准字H20263177 | 2026/01/20 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 海南倍康医药科技有限公司 | 成都倍特药业股份有限公司 | 国药准字H20263176 | 2026/01/20 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 湖南千金湘江药业股份有限公司 | 湖南千金湘江药业股份有限公司 | 国药准字H20256459 | 2025/12/30 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 湖南千金湘江药业股份有限公司 | 湖南千金湘江药业股份有限公司 | 国药准字H20256458 | 2025/12/30 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 重庆康刻尔制药股份有限公司 | 重庆康刻尔制药股份有限公司 | 国药准字H20255773 | 2025/10/21 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 重庆康刻尔制药股份有限公司 | 重庆康刻尔制药股份有限公司 | 国药准字H20255772 | 2025/10/21 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 悦康药业集团股份有限公司 | 悦康药业集团股份有限公司 | 国药准字H20255613 | 2025/09/30 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 天地恒一制药股份有限公司 | 天地恒一制药股份有限公司 | 国药准字H20255293 | 2025/09/02 | 10mg (按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| KRKA, d.d., Novo mesto | KRKA, d.d., Novo mesto | 国药准字HJ20250090 | 2025/07/29 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 山东新时代药业有限公司 | 山东新时代药业有限公司 | 国药准字H20254235 | 2025/05/20 | 10mg(按C21H25CIO6 计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 惠升生物制药股份有限公司 | 南京海纳制药有限公司 | 国药准字H20253933 | 2025/04/15 | 5mg (按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 河南立诺制药有限公司 | 天津汉瑞药业有限公司 | 国药准字H20253905 | 2025/04/15 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 惠升生物制药股份有限公司 | 南京海纳制药有限公司 | 国药准字H20253934 | 2025/04/15 | 10mg (按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 河南立诺制药有限公司 | 天津汉瑞药业有限公司 | 国药准字H20253906 | 2025/04/15 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 福元药业有限公司 | 福元药业有限公司 | 国药准字H20253764 | 2025/04/01 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 江苏万高药业股份有限公司 | 江苏万高药业股份有限公司 | 国药准字H20253768 | 2025/04/01 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 江苏万高药业股份有限公司 | 江苏万高药业股份有限公司 | 国药准字H20253767 | 2025/04/01 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 福元药业有限公司 | 福元药业有限公司 | 国药准字H20253782 | 2025/04/01 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| Hetero Labs Limited | Hetero Labs Limited | 国药准字HJ20250030 | 2025/03/18 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| Hetero Labs Limited | Hetero Labs Limited | 国药准字HJ20250029 | 2025/03/18 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 江苏德源药业股份有限公司 | 江苏德源药业股份有限公司 | 国药准字H20253316 | 2025/01/24 | 10mg(以C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 江苏德源药业股份有限公司 | 江苏德源药业股份有限公司 | 国药准字H20253315 | 2025/01/24 | 5mg(以C21H25ClO6计)) | 按化学药品新注册分类批准的仿制药 | CDE |
| 河北智恒医药科技股份有限公司 | 新华制药(高密)有限公司 | 国药准字H20253304 | 2025/01/24 | 10mg (以C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 湖南九典制药股份有限公司 | 湖南九典制药股份有限公司 | 国药准字H20249826 | 2024/12/25 | 10mg(以C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 浙江华海药业股份有限公司 | 浙江华海药业股份有限公司 | 国药准字H20249659 | 2024/12/01 | 5mg (以C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 浙江华义制药有限公司 | 浙江华义制药有限公司 | 国药准字H20249541 | 2024/12/01 | 10mg(以C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 浙江华义制药有限公司 | 浙江华义制药有限公司 | 国药准字H20249540 | 2024/12/01 | 5mg(按C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 浙江华海药业股份有限公司 | 浙江华海药业股份有限公司 | 国药准字H20249660 | 2024/12/01 | 10mg (以C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 北京伟林恒昌医药科技有限公司 | 北京京丰制药集团有限公司 | 国药准字H20249285 | 2024/11/05 | 5mg(以C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 北京伟林恒昌医药科技有限公司 | 北京京丰制药集团有限公司 | 国药准字H20249286 | 2024/11/05 | 10mg(以C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 昆山龙灯瑞迪制药有限公司 | 昆山龙灯瑞迪制药有限公司 | 国药准字H20244736 | 2024/08/27 | 5mg(以C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 齐鲁制药有限公司 | 齐鲁制药有限公司 | 国药准字H20244734 | 2024/08/27 | 10mg(按C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 齐鲁制药有限公司 | 齐鲁制药有限公司 | 国药准字H20244735 | 2024/08/27 | 5mg(按C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 昆山龙灯瑞迪制药有限公司 | 昆山龙灯瑞迪制药有限公司 | 国药准字H20244737 | 2024/08/27 | 10mg(以C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 浙江诺得药业有限公司 | 浙江诺得药业有限公司 | 国药准字H20244368 | 2024/06/28 | 10mg(以C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 石家庄四药有限公司 | 石家庄四药有限公司 | 国药准字H20244369 | 2024/06/28 | 5mg(以C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 石家庄四药有限公司 | 石家庄四药有限公司 | 国药准字H20244370 | 2024/06/28 | 10mg(以C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 浙江诺得药业有限公司 | 浙江诺得药业有限公司 | 国药准字H20244367 | 2024/06/28 | 5mg(以C<sub>21</sub>H<sub>25</sub>ClO<sub>6</sub>计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 宁波美诺华天康药业有限公司 | 宁波美诺华天康药业有限公司 | 国药准字H20244146 | 2024/06/25 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 宁波美诺华天康药业有限公司 | 宁波美诺华天康药业有限公司 | 国药准字H20244145 | 2024/06/25 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| M/s Cipla Ltd. | M/s Cipla Ltd. | 国药准字HJ20240025 | 2024/05/21 | 10mg(以C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 石药集团欧意药业有限公司 | 石药集团欧意药业有限公司 | 国药准字H20243380 | 2024/03/19 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 石药集团欧意药业有限公司 | 石药集团欧意药业有限公司 | 国药准字H20243381 | 2024/03/19 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 成都倍特药业股份有限公司 | 成都倍特药业股份有限公司 | 国药准字H20243086 | 2024/01/23 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 成都倍特药业股份有限公司 | 成都倍特药业股份有限公司 | 国药准字H20243087 | 2024/01/23 | 5mg(以C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 南京方生和医药科技有限公司 | 以岭万洲国际制药有限公司 | 国药准字H20234636 | 2023/12/13 | 10mg(以C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 阿斯利康药业(中国)有限公司 | 阿斯利康药业(中国)有限公司 | 国药准字H20234464 | 2023/11/07 | 5mg (以C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 阿斯利康药业(中国)有限公司 | 阿斯利康药业(中国)有限公司 | 国药准字H20234463 | 2023/11/07 | 10mg (以C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 南京正大天晴制药有限公司 | 南京正大天晴制药有限公司 | 国药准字H20234191 | 2023/09/28 | 10mg(以C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 江苏豪森药业集团有限公司 | 江苏豪森药业集团有限公司 | 国药准字H20233762 | 2023/06/21 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 江苏豪森药业集团有限公司 | 江苏豪森药业集团有限公司 | 国药准字H20233761 | 2023/06/21 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 北京双鹭药业股份有限公司 | 北京双鹭药业股份有限公司 | 国药准字H20233316 | 2023/03/21 | 10mg(以C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 北京双鹭药业股份有限公司 | 北京双鹭药业股份有限公司 | 国药准字H20233315 | 2023/03/21 | 5mg(以C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 北京福元医药股份有限公司 | 北京福元医药股份有限公司 | 国药准字H20213836 | 2021/10/26 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 山东鲁抗医药股份有限公司 | 山东鲁抗医药股份有限公司 | 国药准字H20213815 | 2021/10/26 | 5mg(以C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 山东鲁抗医药股份有限公司 | 山东鲁抗医药股份有限公司 | 国药准字H20213816 | 2021/10/26 | 10mg(以C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| AstraZeneca AB | AstraZeneca Pharmaceuticals LP | H20170119;H20170120;H20170206 | 2017/03/10 | 10mg(以C21H25ClO6计) | 进口原研药品 | CDE |
| AstraZeneca AB | AstraZeneca Pharmaceuticals LP | H20170117;H20170118;H20170205 | 2017/03/10 | 5mg(以C21H25ClO6计) | 进口原研药品 | CDE |
| 苏州第壹制药有限公司 | 苏州第壹制药有限公司 | 国药准字H20266379 | 2026/10/20 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 苏州第壹制药有限公司 | 苏州第壹制药有限公司 | 国药准字H20266380 | 2026/10/20 | 10mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
| 重庆科瑞南海制药有限责任公司 | 重庆科瑞南海制药有限责任公司 | 国药准字H20266274 | 2026/10/13 | 5mg(按C21H25ClO6计) | 按化学药品新注册分类批准的仿制药 | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 62 distinct approval numbers and 36 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 石家庄市华新药业有限责任公司 | 国药准字H20263477 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010102753 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263203 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010102877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263950 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010104127 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263217 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010107011 | NHSA |
| 合肥合源药业有限公司 | 国药准字H20265802 | 10mg(按 C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010109541 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265370 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010109637 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263619 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010181767 | NHSA |
| 任曦医药科技河北有限公司 | 国药准字H20263290 | 10mg (按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010183846 | NHSA |
| 海南倍康医药科技有限公司 | 国药准字H20263176 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010185151 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20263477 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010202753 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263203 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010202877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263950 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010204127 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263217 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010207011 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265370 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010209637 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263619 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010281767 | NHSA |
| 任曦医药科技河北有限公司 | 国药准字H20263290 | 10mg (按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010283846 | NHSA |
| 海南倍康医药科技有限公司 | 国药准字H20263176 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010285151 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20263477 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010302753 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263203 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010302877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263950 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010304127 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263217 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010307011 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265370 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010309637 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263619 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010381767 | NHSA |
| 任曦医药科技河北有限公司 | 国药准字H20263290 | 10mg (按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010383846 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20263477 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010402753 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263203 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010402877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263950 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010404127 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265370 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010409637 | NHSA |
| 任曦医药科技河北有限公司 | 国药准字H20263290 | 10mg (按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010483846 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20263477 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010502753 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263203 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010502877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263950 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010504127 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265370 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010509637 | NHSA |
| 任曦医药科技河北有限公司 | 国药准字H20263290 | 10mg (按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010583846 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20263477 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010602753 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263203 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010602877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263950 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010604127 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265370 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010609637 | NHSA |
| 任曦医药科技河北有限公司 | 国药准字H20263290 | 10mg (按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010683846 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20263477 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010702753 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263203 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010702877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263950 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010704127 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265370 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010709637 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20263477 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010802753 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263203 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010802877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263950 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010804127 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265370 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010809637 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20263477 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010902753 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263950 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010904127 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20263477 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011002753 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263950 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011004127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263950 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011104127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263950 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011204127 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263204 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020102877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263949 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020104127 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20269126 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020104188 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020107011 | NHSA |
| 合肥合源药业有限公司 | 国药准字H20265803 | 5mg(按 C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020109541 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265369 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020109637 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263620 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020181767 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263204 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020202877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263949 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020204127 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20269126 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020204188 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020207011 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265369 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020209637 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263620 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020281767 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263204 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020302877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263949 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020304127 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20269126 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020304188 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020307011 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265369 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020309637 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263620 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020381767 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263204 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020402877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263949 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020404127 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020407011 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265369 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020409637 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263204 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020502877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263949 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020504127 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020507011 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265369 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020509637 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263204 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020602877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263949 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020604127 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020607011 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265369 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020609637 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263204 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020702877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263949 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020704127 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020707011 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265369 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020709637 | NHSA |
| 山西德元堂药业有限公司 | 国药准字H20263204 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020802877 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263949 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020804127 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020807011 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263949 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020904127 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020907011 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263949 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021004127 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021007011 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263949 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021104127 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021107011 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20263949 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021204127 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021207011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021307011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021407011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021507011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021607011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021707011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021807011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021907011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022007011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022107011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022207011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022307011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022407011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022507011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022607011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022707011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022807011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263216 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001030107011 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20265369 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001030109637 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263619 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001030181767 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263619 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001030281767 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263619 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001030381767 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263619 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001030481767 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263619 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001030581767 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263619 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001030681767 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263619 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001030781767 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263620 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001040181767 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263620 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001040281767 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263620 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001040381767 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263620 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001040481767 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263620 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001040581767 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263620 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001040681767 | NHSA |
| 辽宁鑫善源药业有限公司 | 国药准字H20263620 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001040781767 | NHSA |
| 北京双鹭药业股份有限公司 | 国药准字H20233315 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010100148 | NHSA |
| 北京福元医药股份有限公司 | 国药准字H20213836 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010100177 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20255613 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010100239 | NHSA |
| AstraZeneca AB | 国药准字J20170040 | 10mg(以C21H25ClO6计) | 乙 | XA10BKD256A001010101359 | NHSA |
| 昆山龙灯瑞迪制药有限公司 | 国药准字H20244736 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010101533 | NHSA |
| 南京正大天晴制药有限公司 | 国药准字H20234196 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010101606 | NHSA |
| 石家庄四药有限公司 | 国药准字H20244369 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010102763 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20243380 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010102770 | NHSA |
| 宁波美诺华天康药业有限公司 | 国药准字H20244145 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010104565 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20249659 | 5mg (以C21H25ClO6计) | 乙 | XA10BKD256A001010104647 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20249540 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010104650 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010104942 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20253315 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010106632 | NHSA |
| 阿斯利康药业(中国)有限公司 | 国药准字H20234463 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010110153 | NHSA |
| AstraZeneca AB | 国药准字HJ20170119 | 10mg(以C21H25ClO6计) | 乙 | XA10BKD256A001010179096 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010179426 | NHSA |
| M/s Cipla Ltd. | 国药准字HJ20240025 | 10mg(以 C₂₁H₂₅ClO₆ 计) | 乙 | XA10BKD256A001010179537 | NHSA |
| 天地恒一制药股份有限公司 | 国药准字H20255293 | 10mg (按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010180086 | NHSA |
| 福元药业有限公司 | 国药准字H20253764 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010180651 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20213815 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010183198 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249285 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010183203 | NHSA |
| 南京方生和医药科技有限公司 | 国药准字H20234636 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010183343 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010183521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010183775 | NHSA |
| KRKA,d.d., Novo mesto | 国药准字HJ20250090 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010184240 | NHSA |
| 河南立诺制药有限公司 | 国药准字H20253905 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010185024 | NHSA |
| 北京福元医药股份有限公司 | 国药准字H20213836 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010200177 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20255613 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010200239 | NHSA |
| AstraZeneca AB | 国药准字J20170040 | 10mg(以C21H25ClO6计) | 乙 | XA10BKD256A001010201359 | NHSA |
| 江苏豪森药业集团有限公司 | 国药准字H20233761 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010201444 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20243380 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010202770 | NHSA |
| 宁波美诺华天康药业有限公司 | 国药准字H20244145 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010204565 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20249659 | 5mg (以C21H25ClO6计) | 乙 | XA10BKD256A001010204647 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010204942 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20253315 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010206632 | NHSA |
| 阿斯利康药业(中国)有限公司 | 国药准字H20234463 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010210153 | NHSA |
| AstraZeneca AB | 国药准字HJ20170119 | 10mg(以C21H25ClO6计) | 乙 | XA10BKD256A001010279096 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010279426 | NHSA |
| 天地恒一制药股份有限公司 | 国药准字H20255293 | 10mg (按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010280086 | NHSA |
| 福元药业有限公司 | 国药准字H20253764 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010280651 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20213815 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010283198 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249285 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010283203 | NHSA |
| 南京方生和医药科技有限公司 | 国药准字H20234636 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010283343 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010283521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010283775 | NHSA |
| KRKA,d.d., Novo mesto | 国药准字HJ20250090 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010284240 | NHSA |
| 河南立诺制药有限公司 | 国药准字H20253905 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010285024 | NHSA |
| 北京福元医药股份有限公司 | 国药准字H20213836 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010300177 | NHSA |
| AstraZeneca AB | 国药准字J20170040 | 10mg(以C21H25ClO6计) | 乙 | XA10BKD256A001010301359 | NHSA |
| 江苏豪森药业集团有限公司 | 国药准字H20233761 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010301444 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20249659 | 5mg (以C21H25ClO6计) | 乙 | XA10BKD256A001010304647 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010304942 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20253315 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010306632 | NHSA |
| AstraZeneca AB | 国药准字HJ20170120 | 10mg(以C21H25ClO6计) | 乙 | XA10BKD256A001010379096 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010379426 | NHSA |
| 福元药业有限公司 | 国药准字H20253764 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010380651 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20213815 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010383198 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249285 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010383203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010383521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010383775 | NHSA |
| KRKA,d.d., Novo mesto | 国药准字HJ20250090 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010384240 | NHSA |
| 北京福元医药股份有限公司 | 国药准字H20213836 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010400177 | NHSA |
| 江苏豪森药业集团有限公司 | 国药准字H20233761 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010401444 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20254235 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010404188 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20249659 | 5mg (以C21H25ClO6计) | 乙 | XA10BKD256A001010404647 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010404942 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20253315 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010406632 | NHSA |
| AstraZeneca AB | 国药准字HJ20170120 | 10mg(以C21H25ClO6计) | 乙 | XA10BKD256A001010479096 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010479426 | NHSA |
| 福元药业有限公司 | 国药准字H20253764 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010480651 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20213815 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010483198 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249285 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010483203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010483521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010483775 | NHSA |
| KRKA,d.d., Novo mesto | 国药准字HJ20250090 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010484240 | NHSA |
| 北京福元医药股份有限公司 | 国药准字H20213836 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010500177 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20254235 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010504188 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010504942 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20253315 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010506632 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010579426 | NHSA |
| 福元药业有限公司 | 国药准字H20253764 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010580651 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249285 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010583203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010583521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010583775 | NHSA |
| 北京福元医药股份有限公司 | 国药准字H20213836 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010600177 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20254235 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010604188 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010604942 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010679426 | NHSA |
| 福元药业有限公司 | 国药准字H20253764 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010680651 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249285 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010683203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010683521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010683775 | NHSA |
| 北京福元医药股份有限公司 | 国药准字H20213836 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010700177 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010704942 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010779426 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249285 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010783203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010783521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010783775 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010804942 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010879426 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249285 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010883203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010883521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010883775 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010904942 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010983521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010983775 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011004942 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011083521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011083775 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011104942 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011183521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011183775 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011204942 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011283521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011283775 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011304942 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011383521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011383775 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011404942 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011483521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011483775 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011504942 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011583521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011583775 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011604942 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011683521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011683775 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011704942 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011783521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011783775 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011804942 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011883521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011883775 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011904942 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011983521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001011983775 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012004942 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012083521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012083775 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249826 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012104942 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012183521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012183775 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012283521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012283775 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012383521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012383775 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012483521 | NHSA |
| 河北智恒医药科技股份有限公司 | 国药准字H20253304 | 10mg (以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012483775 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012583521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012683521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012783521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001012983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001013083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001013183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001013283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001013383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001013483521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001013583521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001013683521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001013783521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001013883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001013983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001014083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001014183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001014283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001014383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001014483521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244367 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001014583521 | NHSA |
| 北京双鹭药业股份有限公司 | 国药准字H20233316 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020100148 | NHSA |
| AstraZeneca AB | 国药准字J20170039 | 5mg(以C21H25ClO6计) | 乙 | XA10BKD256A001020101359 | NHSA |
| 昆山龙灯瑞迪制药有限公司 | 国药准字H20244737 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020101533 | NHSA |
| 南京正大天晴制药有限公司 | 国药准字H20234191 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020101606 | NHSA |
| 石家庄四药有限公司 | 国药准字H20244370 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020102763 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20243381 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020102770 | NHSA |
| 宁波美诺华天康药业有限公司 | 国药准字H20244146 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020104565 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20249660 | 10mg (以C21H25ClO6计) | 乙 | XA10BKD256A001020104647 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20249541 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020104650 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20253316 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020106632 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020179426 | NHSA |
| 福元药业有限公司 | 国药准字H20253782 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020180651 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20213816 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020183198 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020183203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020183521 | NHSA |
| 河南立诺制药有限公司 | 国药准字H20253906 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020185024 | NHSA |
| AstraZeneca AB | 国药准字J20170039 | 5mg(以C21H25ClO6计) | 乙 | XA10BKD256A001020201359 | NHSA |
| 江苏豪森药业集团有限公司 | 国药准字H20233762 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020201444 | NHSA |
| 昆山龙灯瑞迪制药有限公司 | 国药准字H20244737 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020201533 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20243381 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020202770 | NHSA |
| 宁波美诺华天康药业有限公司 | 国药准字H20244146 | 5mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020204565 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20249660 | 10mg (以C21H25ClO6计) | 乙 | XA10BKD256A001020204647 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20253316 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020206632 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020279426 | NHSA |
| 福元药业有限公司 | 国药准字H20253782 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020280651 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20213816 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020283198 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020283203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020283521 | NHSA |
| 河南立诺制药有限公司 | 国药准字H20253906 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020285024 | NHSA |
| 昆山龙灯瑞迪制药有限公司 | 国药准字H20244737 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020301533 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20249660 | 10mg (以C21H25ClO6计) | 乙 | XA10BKD256A001020304647 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20253316 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020306632 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020379426 | NHSA |
| 福元药业有限公司 | 国药准字H20253782 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020380651 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20213816 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020383198 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020383203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020383521 | NHSA |
| 昆山龙灯瑞迪制药有限公司 | 国药准字H20244737 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020401533 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20249660 | 10mg (以C21H25ClO6计) | 乙 | XA10BKD256A001020404647 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20253316 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020406632 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020479426 | NHSA |
| 福元药业有限公司 | 国药准字H20253782 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020480651 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20213816 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020483198 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020483203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020483521 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20249660 | 10mg (以C21H25ClO6计) | 乙 | XA10BKD256A001020504647 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20253316 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020506632 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020579426 | NHSA |
| 福元药业有限公司 | 国药准字H20253782 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020580651 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020583203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020583521 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20249660 | 10mg (以C21H25ClO6计) | 乙 | XA10BKD256A001020604647 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020679426 | NHSA |
| 福元药业有限公司 | 国药准字H20253782 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020680651 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020683203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020683521 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020779426 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020783203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020783521 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | 10mg(按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020879426 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020883203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020883521 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020983203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001020983521 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021083203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021083521 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021183203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021183521 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021283203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021283521 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021383203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021383521 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021483203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021483521 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021583203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021583521 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021683203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021683521 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021783203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021783521 | NHSA |
| 优辉药业(北京)有限公司 | 国药准字H20249286 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021883203 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001021983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022483521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022583521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022683521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022783521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001022983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001023083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001023183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001023283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001023383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001023483521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001023583521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001023683521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001023783521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001023883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001023983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001024083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001024183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001024283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001024383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001024483521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244368 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001024583521 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20213815 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001030183198 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20213815 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001030283198 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20213815 | 5mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001030383198 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20213816 | 10mg(以C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001040183198 | NHSA |
| 任曦医药科技河北有限公司 | 国药准字H20263290 | 10mg (按C₂₁H₂₅ClO₆计) | 乙 | XA10BKD256A001010783846 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 82 filings and 47 distinct first applicants.
Supplement 4 · Generic 78
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 湖南九典制药股份有限公司 | CYHB2601896 | Supplement | 2026/10/15 | Not stated by source | CDE |
| 江西施美药业股份有限公司 | CYHS2602530 | Generic | 2026/10/14 | Not stated by source | CDE |
| 江西施美药业股份有限公司 | CYHS2602529 | Generic | 2026/10/14 | Not stated by source | CDE |
| 江右制药(常德)有限公司;烟台东诚大洋制药有限公司 | CYHS2602379 | Generic | 2026/09/22 | Not stated by source | CDE |
| 江右制药(常德)有限公司;烟台东诚大洋制药有限公司 | CYHS2602378 | Generic | 2026/09/22 | Not stated by source | CDE |
| 朝阳龙城制药有限公司 | CYHS2602295 | Generic | 2026/09/16 | Not stated by source | CDE |
| 朝阳龙城制药有限公司 | CYHS2602294 | Generic | 2026/09/16 | Not stated by source | CDE |
| 山东鲁抗医药股份有限公司 | CYHB2601679 | Supplement | 2026/09/03 | Not stated by source | CDE |
| 山东鲁抗医药股份有限公司 | CYHB2601678 | Supplement | 2026/09/03 | Not stated by source | CDE |
| 山东鲁抗医药集团赛特有限责任公司 | CYHS2602153 | Generic | 2026/08/28 | Not stated by source | CDE |
| 山东鲁抗医药集团赛特有限责任公司 | CYHS2602152 | Generic | 2026/08/28 | Not stated by source | CDE |
| 太康海恩药业有限公司 | CYHS2602126 | Generic | 2026/08/26 | Not stated by source | CDE |
| 太康海恩药业有限公司 | CYHS2602125 | Generic | 2026/08/26 | Not stated by source | CDE |
| 重庆药友制药有限责任公司 | CYHS2602007 | Generic | 2026/08/13 | Not stated by source | CDE |
| 重庆药友制药有限责任公司 | CYHS2602006 | Generic | 2026/08/13 | Not stated by source | CDE |
| 浙江江北药业有限公司 | CYHS2601938 | Generic | 2026/08/10 | Not stated by source | CDE |
| 浙江江北药业有限公司 | CYHS2601937 | Generic | 2026/08/10 | Not stated by source | CDE |
| 湖北省宏源药业科技股份有限公司;湖北同德堂药业有限公司 | CYHS2601897 | Generic | 2026/08/05 | Not stated by source | CDE |
| 湖北省宏源药业科技股份有限公司;湖北同德堂药业有限公司 | CYHS2601896 | Generic | 2026/08/05 | Not stated by source | CDE |
| 陕西白鹿制药股份有限公司 | CYHS2601837 | Generic | 2026/07/30 | Not stated by source | CDE |
| 陕西白鹿制药股份有限公司 | CYHS2601836 | Generic | 2026/07/30 | Not stated by source | CDE |
| 翎耀生物科技(上海)有限公司;江苏诚康药业有限公司 | CYHS2601806 | Generic | 2026/07/28 | Not stated by source | CDE |
| 翎耀生物科技(上海)有限公司;江苏诚康药业有限公司 | CYHS2601805 | Generic | 2026/07/28 | Not stated by source | CDE |
| 北京赛而生物药业有限公司 | CYHS2601778 | Generic | 2026/07/24 | Not stated by source | CDE |
| 北京赛而生物药业有限公司 | CYHS2601777 | Generic | 2026/07/24 | Not stated by source | CDE |
| 河北万岁药业有限公司 | CYHS2601768 | Generic | 2026/07/23 | Not stated by source | CDE |
| 河北万岁药业有限公司 | CYHS2601767 | Generic | 2026/07/23 | Not stated by source | CDE |
| 替克(湖北)医药有限公司;湖北济安堂药业股份有限公司 | CYHS2601623 | Generic | 2026/07/08 | Not stated by source | CDE |
| 山东丹红制药有限公司;杨凌步长制药有限公司 | CYHS2601446 | Generic | 2026/06/18 | Not stated by source | CDE |
| 山东丹红制药有限公司;杨凌步长制药有限公司 | CYHS2601445 | Generic | 2026/06/18 | Not stated by source | CDE |
| 任曦医药科技河北有限公司;天方药业有限公司 | CYHB2601145 | Supplement | 2026/06/17 | Not stated by source | CDE |
| 迪沙药业集团有限公司 | CYHS2601369 | Generic | 2026/06/10 | Not stated by source | CDE |
| 扬子江药业集团上海海尼药业有限公司 | CYHS2601300 | Generic | 2026/06/04 | Not stated by source | CDE |
| 江苏欧歌制药有限公司 | CYHS2601229 | Generic | 2026/06/01 | Not stated by source | CDE |
| 江苏欧歌制药有限公司 | CYHS2601228 | Generic | 2026/06/01 | Not stated by source | CDE |
| 海南皇隆制药股份有限公司 | CYHS2601130 | Generic | 2026/05/14 | Not stated by source | CDE |
| 海南皇隆制药股份有限公司 | CYHS2601126 | Generic | 2026/05/14 | Not stated by source | CDE |
| 乐泰药业有限公司 | CYHS2601056 | Generic | 2026/05/08 | Not stated by source | CDE |
| 乐泰药业有限公司 | CYHS2601055 | Generic | 2026/05/08 | Not stated by source | CDE |
| 湖北广济药业股份有限公司 | CYHS2600934 | Generic | 2026/04/23 | Not stated by source | CDE |
| 湖北广济药业股份有限公司 | CYHS2600933 | Generic | 2026/04/23 | Not stated by source | CDE |
| 华益药业科技(安徽)有限公司 | CYHS2600601 | Generic | 2026/03/02 | Not stated by source | CDE |
| 华益药业科技(安徽)有限公司 | CYHS2600600 | Generic | 2026/03/02 | Not stated by source | CDE |
| 上海衡山药业有限公司 | CYHS2600365 | Generic | 2026/02/04 | Not stated by source | CDE |
| 湖南威特制药股份有限公司 | CYHS2600330 | Generic | 2026/01/31 | Not stated by source | CDE |
| 山东诺禾康药业有限公司 | CYHS2600265 | Generic | 2026/01/23 | Not stated by source | CDE |
| 山东诺禾康药业有限公司 | CYHS2600264 | Generic | 2026/01/23 | Not stated by source | CDE |
| 华泰民康(沈阳)科技有限公司;辽宁康博士制药有限公司 | CYHS2600220 | Generic | 2026/01/20 | Not stated by source | CDE |
| 华泰民康(沈阳)科技有限公司;辽宁康博士制药有限公司 | CYHS2600219 | Generic | 2026/01/20 | Not stated by source | CDE |
| 新乡市常乐制药有限责任公司 | CYHS2600211 | Generic | 2026/01/17 | Not stated by source | CDE |
| 新乡市常乐制药有限责任公司 | CYHS2600210 | Generic | 2026/01/17 | Not stated by source | CDE |
| 山东诚创蓝海医药科技有限公司;远大生命科学(山东)有限公司 | CYHS2600090 | Generic | 2026/01/08 | Not stated by source | CDE |
| 山东诚创蓝海医药科技有限公司;远大生命科学(山东)有限公司 | CYHS2600089 | Generic | 2026/01/08 | Not stated by source | CDE |
| 江苏神华药业有限公司 | CYHS2503762 | Generic | 2025/10/22 | Not stated by source | CDE |
| 江苏亚邦爱普森药业有限公司 | CYHS2503980 | Generic | 2025/11/18 | Not stated by source | CDE |
| 江苏亚邦爱普森药业有限公司 | CYHS2503979 | Generic | 2025/11/18 | Not stated by source | CDE |
| 江西制药有限责任公司 | CYHS2602580 | Generic | 2026/10/21 | Not stated by source | CDE |
| 江西制药有限责任公司 | CYHS2602579 | Generic | 2026/10/21 | Not stated by source | CDE |
| 双鹤天安药业(贵州)股份有限公司 | CYHS2504435 | Generic | 2025/12/26 | Not stated by source | CDE |
| 双鹤天安药业(贵州)股份有限公司 | CYHS2504434 | Generic | 2025/12/26 | Not stated by source | CDE |
| 云鹏医药集团有限公司 | CYHS2504385 | Generic | 2025/12/25 | Not stated by source | CDE |
| 山东鲁宁药业有限公司 | CYHS2504366 | Generic | 2025/12/24 | Not stated by source | CDE |
| 山东鲁宁药业有限公司 | CYHS2504365 | Generic | 2025/12/24 | Not stated by source | CDE |
| 浙江为康制药有限公司 | CYHS2504189 | Generic | 2025/12/05 | Not stated by source | CDE |
| 浙江为康制药有限公司 | CYHS2504188 | Generic | 2025/12/05 | Not stated by source | CDE |
| 四川新斯顿制药股份有限公司 | CYHS2503891 | Generic | 2025/11/06 | Not stated by source | CDE |
| 四川新斯顿制药股份有限公司 | CYHS2503890 | Generic | 2025/11/06 | Not stated by source | CDE |
| 浙江普洛康裕制药有限公司 | CYHS2503766 | Generic | 2025/10/22 | Not stated by source | CDE |
| 浙江普洛康裕制药有限公司 | CYHS2503765 | Generic | 2025/10/22 | Not stated by source | CDE |
| 四川益生智同医药生物科技发展有限公司;重庆博腾药业有限公司 | CYHS2503358 | Generic | 2025/09/10 | Not stated by source | CDE |
| 四川益生智同医药生物科技发展有限公司;重庆博腾药业有限公司 | CYHS2503356 | Generic | 2025/09/10 | Not stated by source | CDE |
| 河南普瑞药业有限公司 | CYHS2503255 | Generic | 2025/09/04 | Not stated by source | CDE |
| 河南普瑞药业有限公司 | CYHS2503254 | Generic | 2025/09/04 | Not stated by source | CDE |
| 青岛百洋制药有限公司 | CYHS2502956 | Generic | 2025/08/13 | Not stated by source | CDE |
| 甘李药业山东有限公司 | CYHS2502790 | Generic | 2025/08/02 | Not stated by source | CDE |
| 天津力生制药股份有限公司 | CYHS2502658 | Generic | 2025/07/23 | Not stated by source | CDE |
| 天津力生制药股份有限公司 | CYHS2502657 | Generic | 2025/07/23 | Not stated by source | CDE |
| 浙江麒正药业有限公司 | CYHS2502418 | Generic | 2025/07/08 | Not stated by source | CDE |
| 浙江麒正药业有限公司 | CYHS2502417 | Generic | 2025/07/08 | Not stated by source | CDE |
| 天方药业有限公司 | CYHS2501871 | Generic | 2025/05/24 | Not stated by source | CDE |
| 天方药业有限公司 | CYHS2501870 | Generic | 2025/05/24 | Not stated by source | CDE |
| 四川国为制药有限公司 | CYHS2102104 | Generic | 2021/11/30 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 51 filings and 28 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 江西施美药业股份有限公司 | CYHS2602530 | Generic | 2026/10/14 | Not stated by source | CDE |
| 江西施美药业股份有限公司 | CYHS2602529 | Generic | 2026/10/14 | Not stated by source | CDE |
| 江右制药(常德)有限公司;烟台东诚大洋制药有限公司 | CYHS2602379 | Generic | 2026/09/22 | Not stated by source | CDE |
| 江右制药(常德)有限公司;烟台东诚大洋制药有限公司 | CYHS2602378 | Generic | 2026/09/22 | Not stated by source | CDE |
| 朝阳龙城制药有限公司 | CYHS2602295 | Generic | 2026/09/16 | Not stated by source | CDE |
| 朝阳龙城制药有限公司 | CYHS2602294 | Generic | 2026/09/16 | Not stated by source | CDE |
| 山东鲁抗医药集团赛特有限责任公司 | CYHS2602153 | Generic | 2026/08/28 | Not stated by source | CDE |
| 山东鲁抗医药集团赛特有限责任公司 | CYHS2602152 | Generic | 2026/08/28 | Not stated by source | CDE |
| 太康海恩药业有限公司 | CYHS2602126 | Generic | 2026/08/26 | Not stated by source | CDE |
| 太康海恩药业有限公司 | CYHS2602125 | Generic | 2026/08/26 | Not stated by source | CDE |
| 重庆药友制药有限责任公司 | CYHS2602007 | Generic | 2026/08/13 | Not stated by source | CDE |
| 重庆药友制药有限责任公司 | CYHS2602006 | Generic | 2026/08/13 | Not stated by source | CDE |
| 浙江江北药业有限公司 | CYHS2601938 | Generic | 2026/08/10 | Not stated by source | CDE |
| 浙江江北药业有限公司 | CYHS2601937 | Generic | 2026/08/10 | Not stated by source | CDE |
| 湖北省宏源药业科技股份有限公司;湖北同德堂药业有限公司 | CYHS2601897 | Generic | 2026/08/05 | Not stated by source | CDE |
| 湖北省宏源药业科技股份有限公司;湖北同德堂药业有限公司 | CYHS2601896 | Generic | 2026/08/05 | Not stated by source | CDE |
| 陕西白鹿制药股份有限公司 | CYHS2601837 | Generic | 2026/07/30 | Not stated by source | CDE |
| 陕西白鹿制药股份有限公司 | CYHS2601836 | Generic | 2026/07/30 | Not stated by source | CDE |
| 翎耀生物科技(上海)有限公司;江苏诚康药业有限公司 | CYHS2601806 | Generic | 2026/07/28 | Not stated by source | CDE |
| 翎耀生物科技(上海)有限公司;江苏诚康药业有限公司 | CYHS2601805 | Generic | 2026/07/28 | Not stated by source | CDE |
| 北京赛而生物药业有限公司 | CYHS2601778 | Generic | 2026/07/24 | Not stated by source | CDE |
| 北京赛而生物药业有限公司 | CYHS2601777 | Generic | 2026/07/24 | Not stated by source | CDE |
| 河北万岁药业有限公司 | CYHS2601768 | Generic | 2026/07/23 | Not stated by source | CDE |
| 河北万岁药业有限公司 | CYHS2601767 | Generic | 2026/07/23 | Not stated by source | CDE |
| 替克(湖北)医药有限公司;湖北济安堂药业股份有限公司 | CYHS2601623 | Generic | 2026/07/08 | Not stated by source | CDE |
| 山东丹红制药有限公司;杨凌步长制药有限公司 | CYHS2601446 | Generic | 2026/06/18 | Not stated by source | CDE |
| 山东丹红制药有限公司;杨凌步长制药有限公司 | CYHS2601445 | Generic | 2026/06/18 | Not stated by source | CDE |
| 迪沙药业集团有限公司 | CYHS2601369 | Generic | 2026/06/10 | Not stated by source | CDE |
| 扬子江药业集团上海海尼药业有限公司 | CYHS2601300 | Generic | 2026/06/04 | Not stated by source | CDE |
| 江苏欧歌制药有限公司 | CYHS2601229 | Generic | 2026/06/01 | Not stated by source | CDE |
| 江苏欧歌制药有限公司 | CYHS2601228 | Generic | 2026/06/01 | Not stated by source | CDE |
| 海南皇隆制药股份有限公司 | CYHS2601130 | Generic | 2026/05/14 | Not stated by source | CDE |
| 海南皇隆制药股份有限公司 | CYHS2601126 | Generic | 2026/05/14 | Not stated by source | CDE |
| 乐泰药业有限公司 | CYHS2601056 | Generic | 2026/05/08 | Not stated by source | CDE |
| 乐泰药业有限公司 | CYHS2601055 | Generic | 2026/05/08 | Not stated by source | CDE |
| 湖北广济药业股份有限公司 | CYHS2600934 | Generic | 2026/04/23 | Not stated by source | CDE |
| 湖北广济药业股份有限公司 | CYHS2600933 | Generic | 2026/04/23 | Not stated by source | CDE |
| 华益药业科技(安徽)有限公司 | CYHS2600601 | Generic | 2026/03/02 | Not stated by source | CDE |
| 华益药业科技(安徽)有限公司 | CYHS2600600 | Generic | 2026/03/02 | Not stated by source | CDE |
| 上海衡山药业有限公司 | CYHS2600365 | Generic | 2026/02/04 | Not stated by source | CDE |
| 湖南威特制药股份有限公司 | CYHS2600330 | Generic | 2026/01/31 | Not stated by source | CDE |
| 山东诺禾康药业有限公司 | CYHS2600265 | Generic | 2026/01/23 | Not stated by source | CDE |
| 山东诺禾康药业有限公司 | CYHS2600264 | Generic | 2026/01/23 | Not stated by source | CDE |
| 华泰民康(沈阳)科技有限公司;辽宁康博士制药有限公司 | CYHS2600220 | Generic | 2026/01/20 | Not stated by source | CDE |
| 华泰民康(沈阳)科技有限公司;辽宁康博士制药有限公司 | CYHS2600219 | Generic | 2026/01/20 | Not stated by source | CDE |
| 新乡市常乐制药有限责任公司 | CYHS2600211 | Generic | 2026/01/17 | Not stated by source | CDE |
| 新乡市常乐制药有限责任公司 | CYHS2600210 | Generic | 2026/01/17 | Not stated by source | CDE |
| 山东诚创蓝海医药科技有限公司;远大生命科学(山东)有限公司 | CYHS2600090 | Generic | 2026/01/08 | Not stated by source | CDE |
| 山东诚创蓝海医药科技有限公司;远大生命科学(山东)有限公司 | CYHS2600089 | Generic | 2026/01/08 | Not stated by source | CDE |
| 江西制药有限责任公司 | CYHS2602580 | Generic | 2026/10/21 | Not stated by source | CDE |
| 江西制药有限责任公司 | CYHS2602579 | Generic | 2026/10/21 | Not stated by source | CDE |
API registrations
Non-component matches: 40 companies with A status and 13 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 达格列净 | 天方药业有限公司 | Y20260000662 | I | Exact ingredient | 2026/08/17 | CDE |
| 达格列净 | 江苏阿尔法集团福瑞药业(宿迁)有限公司 | Y20260000249 | I | Exact ingredient | 2026/04/10 | CDE |
| 达格列净 | 湖南千金湘江药业股份有限公司 | Y20260000255 | I | Exact ingredient | 2026/04/09 | CDE |
| 达格列净 | 湖南先施制药有限公司 | Y20250001499 | I | Exact ingredient | 2026/01/13 | CDE |
| 达格列净 | 武穴宏源药业有限公司 | Y20250001044 | I | Exact ingredient | 2025/12/09 | CDE |
| 达格列净 | 长春海悦药业股份有限公司 | Y20250000937 | I | Exact ingredient | 2025/09/04 | CDE |
| 达格列净 | 浙江江北南海药业有限公司 | Y20250000379 | A | Exact ingredient | 2026/10/16 | CDE |
| 达格列净 | 重庆凯林制药有限公司 | Y20240001191 | A | Exact ingredient | 2026/05/12 | CDE |
| 达格列净 | 北京赛而生物药业有限公司 | Y20240001369 | A | Exact ingredient | 2026/04/21 | CDE |
| 达格列净 | 迪嘉药业集团股份有限公司 | Y20240001043 | A | Exact ingredient | 2026/07/20 | CDE |
| 达格列净 | Honour Lab Limited Unit Iii | Y20240000587 | A | Exact ingredient | 2026/10/05 | CDE |
| 达格列净 | 山东诚汇双达药业有限公司 | Y20240000916 | A | Exact ingredient | 2026/10/17 | CDE |
| 达格列净 | 浙江宏元药业股份有限公司 | Y20240000845 | A | Exact ingredient | 2026/05/20 | CDE |
| 达格列净 | 万洋衡水制药有限公司 | Y20240000873 | A | Exact ingredient | 2026/01/05 | CDE |
| 达格列净 | 浙江奥翔药业股份有限公司 | Y20240000835 | A | Exact ingredient | 2025/12/29 | CDE |
| 达格列净 | 湖北天舒药业有限公司 | Y20240000848 | A | Exact ingredient | 2026/10/27 | CDE |
| 达格列净 | 浙江华海药业股份有限公司 | Y20240000545 | A | Exact ingredient | 2026/09/05 | CDE |
| 达格列净 | 天地恒一制药股份有限公司 | Y20240000242 | A | Exact ingredient | 2025/09/04 | CDE |
| 达格列净 | 浙江九洲药业股份有限公司 | Y20240000151 | A | Exact ingredient | 2025/10/17 | CDE |
| 达格列净 | 苏州正济药业有限公司 | Y20230000874 | A | Exact ingredient | 2026/03/27 | CDE |
| 达格列净 | 北京福元医药股份有限公司 | Y20230000752 | A | Exact ingredient | 2024/12/13 | CDE |
| 达格列净 | 江苏德源药业股份有限公司 | Y20230000695 | A | Exact ingredient | 2025/03/08 | CDE |
| 达格列净 | KRKA, d.d., Novo mesto | Y20230000350 | A | Exact ingredient | 2025/08/06 | CDE |
| 达格列净 | 植恩生物技术股份有限公司 | Y20230000618 | A | Exact ingredient | 2026/06/04 | CDE |
| 达格列净 | 白银京宇新药业有限公司 | Y20230000626 | A | Exact ingredient | 2026/04/03 | CDE |
| 达格列净 | MSN Laboratories Private Limited | Y20230000345 | A | Exact ingredient | 2025/07/28 | CDE |
| 达格列净 | 湖南九典宏阳制药有限公司 | Y20230000318 | A | Exact ingredient | 2026/06/09 | CDE |
| 达格列净 | 潍坊市海欣药业有限公司 | Y20230000410 | A | Exact ingredient | 2024/09/05 | CDE |
| 达格列净 | 汉瑞药业(荆门)有限公司 | Y20230000355 | A | Exact ingredient | 2024/11/12 | CDE |
| 达格列净 | 诚达药业股份有限公司 | Y20230000033 | A | Exact ingredient | 2025/10/27 | CDE |
| 达格列净 | 浙江天宇药业股份有限公司 | Y20220001121 | A | Exact ingredient | 2025/04/11 | CDE |
| 达格列净 | Biocon Limited | Y20220000163 | A | Exact ingredient | 2025/09/05 | CDE |
| 达格列净 | 浙江华海药业股份有限公司 | Y20220000893 | A | Exact ingredient | 2025/12/18 | CDE |
| 达格列净 | 宣城美诺华药业有限公司 | Y20220000754 | A | Exact ingredient | 2024/05/30 | CDE |
| 达格列净 | 阜新龙瑞药业有限责任公司 | Y20220000604 | A | Exact ingredient | 2025/05/14 | CDE |
| 达格列净 | 河北国龙制药有限公司 | Y20220000818 | A | Exact ingredient | 2025/12/31 | CDE |
| 达格列净 | 江苏慧聚药业股份有限公司 | Y20220000848 | A | Exact ingredient | 2024/05/31 | CDE |
| 达格列净 | 石药集团欧意药业有限公司 | Y20220000867 | A | Exact ingredient | 2025/10/23 | CDE |
| 达格列净 | MSN Laboratories Private Limited | Y20220000610 | I | Exact ingredient | 2023/11/03 | CDE |
| 达格列净 | 石药集团欧意药业有限公司 | Y20220000658 | I | Exact ingredient | 2022/08/22 | CDE |
| 达格列净 | Dr.Reddy's Laboratories Ltd. | Y20220000123 | A | Exact ingredient | 2025/01/11 | CDE |
| 达格列净 | 江苏慧聚药业股份有限公司 | Y20220000259 | A | Exact ingredient | 2025/07/02 | CDE |
| 达格列净 | 诚达药业股份有限公司 | Y20220000029 | I | Exact ingredient | 2023/05/22 | CDE |
| 达格列净 | 四川国为制药有限公司 | Y20210000979 | A | Exact ingredient | 2023/06/07 | CDE |
| 达格列净 | 江苏普润生物医药有限公司 | Y20210001011 | A | Exact ingredient | 2024/03/21 | CDE |
| 达格列净 | AstraZeneca AB | Y20210000736 | A | Exact ingredient | 2026/05/20 | CDE |
| 达格列净 | Morepen Laboratories Ltd | Y20210000321 | I | Exact ingredient | 2021/07/30 | CDE |
| 达格列净 | Honour Lab Limited, Unit-Ⅲ | Y20210000221 | I | Exact ingredient | 2024/02/27 | CDE |
| 达格列净 | 江苏豪森药业集团有限公司 | Y20210000556 | A | Exact ingredient | 2023/06/29 | CDE |
| 达格列净 | AstraZeneca AB | Y20210000271 | A | Exact ingredient | 2026/08/21 | CDE |
| 达格列净 | Dr. Reddy's Laboratories Ltd. | Y20210000100 | A | Exact ingredient | 2026/07/16 | CDE |
| 达格列净 | 新乡双鹭药业有限公司 | Y20200001479 | A | Exact ingredient | 2023/05/06 | CDE |
| 达格列净 | ZCL Chemicals Limited | Y20200000919 | I | Exact ingredient | 2023/03/24 | CDE |
| 达格列净 | Honour Lab Limited, Unit-III | Y20200000244 | A | Exact ingredient | 2024/01/31 | CDE |
| 达格列净 | 北京福元医药股份有限公司 | Y20200000298 | A | Exact ingredient | 2026/05/15 | CDE |
| 达格列净 | 山东鲁抗医药股份有限公司 | Y20190000428 | A | Exact ingredient | 2026/07/24 | CDE |
| 达格列净 | 安徽森吉制药有限公司 | Y20260000911 | I | Exact ingredient | 2026/11/02 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, supplements, notices and review changes are labelled separately.
This source was last successfully updated at 2026/11/04 18:32; current coverage may be incomplete.
-
2026/10/30No longer listed under review
陕西君可力医药科技有限公司;安徽佳和药业有限公司
CYHS2501890
Fact date: 2026/10/30 · Site observation date: 2026/10/30
Accepted: 2025/05/28
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/10/30No longer listed under review
陕西君可力医药科技有限公司;安徽佳和药业有限公司
CYHS2501889
Fact date: 2026/10/30 · Site observation date: 2026/10/30
Accepted: 2025/05/28
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/10/21Accepted
-
2026/10/21Accepted
-
2026/10/20Marketing application approved
重庆博腾药业有限公司
CYHS2502776 · 国药准字H20266336
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval. NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/05 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
View source · Table row 95 ↗ -
2026/10/20Marketing application approved
重庆博腾药业有限公司
CYHS2502775 · 国药准字H20266335
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval. NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/05 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
View source · Table row 94 ↗ -
2026/10/20Marketing application approved
苏州第壹制药有限公司
CYHS2501382 · 国药准字H20266380
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval. NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/05 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
View source · Table row 51 ↗ -
2026/10/20Marketing application approved
苏州第壹制药有限公司
CYHS2501380 · 国药准字H20266379
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval. NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/05 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
View source · Table row 50 ↗ -
2026/10/15Accepted
-
2026/10/14Accepted
-
2026/10/14Accepted
-
2026/09/22Accepted
江右制药(常德)有限公司;烟台东诚大洋制药有限公司
CYHS2602379
Fact date: 2026/09/22 · Site observation date: 2026/10/21
View source ↗ -
2026/09/22Accepted
江右制药(常德)有限公司;烟台东诚大洋制药有限公司
CYHS2602378
Fact date: 2026/09/22 · Site observation date: 2026/10/21
View source ↗ -
2026/09/16Accepted
-
2026/09/16Accepted
-
2026/09/03Accepted
-
2026/09/03Accepted
-
2026/08/28Accepted
-
2026/08/28Accepted
-
2026/08/26Accepted
-
2026/08/26Accepted
-
2026/08/13Accepted
-
2026/08/13Accepted
-
2026/08/10Accepted
-
2026/08/10Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/05 06:45
- Chemical-drug catalogue
- Last successful update: 2026/11/05 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/05 06:40
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/04 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-21 to 2026-11-05; 1 pages pending. Covers loaded notices only, not a complete historical approval database.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to 达格列净片
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Pilot subscription
Ongoing tracking for selected drugs
¥2,400/ year · pilot price
- A competitive ledger for up to 10 drugs, updated with daily data and available historical comparisons.
- Collected changes routed to designated responsible roles with the daily scheduled send.
- A forwardable weekly project-change digest, with sources for each record.
- Source dates and coverage gaps shown when collection is incomplete.
This form records an activation request; it does not charge or activate a subscription. History begins with records actually accumulated by this site. Scope is confirmed before activation.